Trending...
- Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
- Building a Technology Powerhouse-From AI Drones and Global Acquisitions to Defense, Enterprise Software and the Future of Autonomous Operations $ZENA
~ In a groundbreaking move, the Tacoma City Council has passed Resolution 41609, declaring entheogen-related activities as the lowest law enforcement priority within the city. The resolution, which was brought forward by District 5 Council Member Joe Bushnell and co-sponsored by Mayor Victoria Woodards, At-large Council Member Olgy Diaz, and District 3 Council Member Jamika Scott, aims to open doors for mental health treatment research by decriminalizing entheogens.
Council Member Bushnell, a veteran who lives with PTSD, emphasized the importance of exploring innovative and compassionate approaches to mental health. He stated that in the United States alone, 22 veterans commit suicide every day and as someone who understands the challenges of living with a mental health condition, he sees the potential of entheogens as a beacon of hope. By declaring support for decriminalization, Tacoma can advocate for further research and potentially life-changing treatments.
More on Washingtoner
Entheogens have been scientifically proven to be effective in treating various conditions such as depression, anxiety, addiction, and PTSD. In fact, the FDA has designated psilocybin-assisted therapy as a breakthrough treatment for treatment-resistant depression.
Tacoma now joins other Washington state jurisdictions such as Seattle, Port Townsend, Olympia, and Jefferson County in deprioritizing local enforcement against entheogen-related activities. This move reflects a growing trend towards recognizing the potential benefits of these substances in treating mental health conditions.
The passing of Resolution 41609 is seen as a significant step towards promoting more progressive and compassionate approaches to mental health treatment in Tacoma. With this resolution in place, it is hoped that further research will be conducted on entheogens and their potential therapeutic uses.
Council Member Bushnell, a veteran who lives with PTSD, emphasized the importance of exploring innovative and compassionate approaches to mental health. He stated that in the United States alone, 22 veterans commit suicide every day and as someone who understands the challenges of living with a mental health condition, he sees the potential of entheogens as a beacon of hope. By declaring support for decriminalization, Tacoma can advocate for further research and potentially life-changing treatments.
More on Washingtoner
- The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th
- Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
- Washington Nurse Introduces Nightingale Care Hub to Help Families Organize Care
- HIRO Ostomy Belt Launch by Richard O'Hamill
- New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
Entheogens have been scientifically proven to be effective in treating various conditions such as depression, anxiety, addiction, and PTSD. In fact, the FDA has designated psilocybin-assisted therapy as a breakthrough treatment for treatment-resistant depression.
Tacoma now joins other Washington state jurisdictions such as Seattle, Port Townsend, Olympia, and Jefferson County in deprioritizing local enforcement against entheogen-related activities. This move reflects a growing trend towards recognizing the potential benefits of these substances in treating mental health conditions.
The passing of Resolution 41609 is seen as a significant step towards promoting more progressive and compassionate approaches to mental health treatment in Tacoma. With this resolution in place, it is hoped that further research will be conducted on entheogens and their potential therapeutic uses.
0 Comments
Latest on Washingtoner
- Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
- The Villari Firm, PLLC Named to the 2027 Edition of Best Law Firms
- Spokane: City and County Issue Joint Housing and Homelessness Funding RFP
- Spokane: Council Approves Additional Funding to Prepare for Inclement Weather
- Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration
- Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
- ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
- New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
- Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
- Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
- Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
- PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
- Spokane: City And County Seek Federal Grant to Plan for Road Network Wildfire Resilience
- The Great Junk Hunt Returns to Monroe: Kick Off Your Holiday Shopping at the Ultimate Vintage Treas
- AI Trading Agents Track Aerospace and Defense US Stocks Amid Rising Technology Investment (SATS, GILT, TSAT, IREN, JOBY, LUNR)
- KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
- Evluma's RoadMax Edge Roadway Luminaires Earn DarkSky Approved Status
- Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
- New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
- Tacoma: Public Hearing for Off-Street Parking Code Update Set for December 1